Literature DB >> 15149844

Epidermal growth factor promotes oligodendrocyte process formation and regrowth after injury.

Pamela E Knapp1, Mary H Adams.   

Abstract

Oligodendrocytes (OLs) form myelin within the central nervous system and are targets in numerous demyelinating diseases and injuries. OLs grown in culture maintain the developmental timetable which occurs in vivo and mature into cells with a relatively normal phenotype. In this study, cultured cells are used to test whether EGF can modulate process formation in OLs both before and after transection injury. EGF had no effect on the formation of new processes by OLs at any stage of development. To test the effect of EGF on process outgrowth after injury, mature OLs were selected and injured by laser transection of a single process, then imaged at 24-h intervals for 120 h. EGF promoted the recovery and regrowth of injured processes and also significantly increased outgrowth in uninjured processes. As well, it increased the number of new sprouts formed by OLs after injury. Results suggest that the effects of EGF on process outgrowth are a consequence of EGF interaction with a signaling pathway that is specifically activated within injured OLs. The potent effect of EGF on OL process formation after an injury suggests that modulation of the signaling pathways involved might provide a mechanism to promote remyelination.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149844     DOI: 10.1016/j.yexcr.2004.02.007

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

Review 1.  Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.

Authors:  Arsalan Alizadeh; Soheila Karimi-Abdolrezaee
Journal:  J Physiol       Date:  2016-03-29       Impact factor: 5.182

Review 2.  Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure.

Authors:  Giuseppe Scalabrino
Journal:  Biomedicines       Date:  2022-03-30

3.  Allelic variation in the Tyk2 and EGF genes as potential genetic determinants of CNS repair.

Authors:  Allan J Bieber; Kanitta Suwansrinon; Jason Kerkvliet; Weidong Zhang; Larry R Pease; Moses Rodriguez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 4.  Oligodendroglia and neurotrophic factors in neurodegeneration.

Authors:  Andrew N Bankston; Mariana D Mandler; Yue Feng
Journal:  Neurosci Bull       Date:  2013-04-05       Impact factor: 5.203

Review 5.  Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.

Authors:  Giuseppe Scalabrino; Daniela Veber
Journal:  J Neurol       Date:  2013-10-20       Impact factor: 4.849

6.  Small Molecule Induction of Human Umbilical Stem Cells into MBP-positive Oligodendrocytes in a Defined Three-Dimensional Environment.

Authors:  Hedvika Davis; Xiufang Guo; Stephen Lambert; Maria Stancescu; James J Hickman
Journal:  ACS Chem Neurosci       Date:  2011-11-29       Impact factor: 4.418

7.  Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.

Authors:  Jigisha R Patel; Jessica L Williams; Megan M Muccigrosso; Laindy Liu; Tao Sun; Joshua B Rubin; Robyn S Klein
Journal:  Acta Neuropathol       Date:  2012-08-30       Impact factor: 17.088

8.  Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function.

Authors:  Zaibo Li; Tiefei Dong; Chris Pröschel; Mark Noble
Journal:  PLoS Biol       Date:  2007-02       Impact factor: 8.029

Review 9.  Enhancing the Therapeutic Potential of Olfactory Ensheathing Cells in Spinal Cord Repair Using Neurotrophins.

Authors:  A A Wright; M Todorovic; J Tello-Velasquez; A J Rayfield; J A St John; J A Ekberg
Journal:  Cell Transplant       Date:  2018-05-31       Impact factor: 4.064

Review 10.  Epidermal Growth Factor in the CNS: A Beguiling Journey from Integrated Cell Biology to Multiple Sclerosis. An Extensive Translational Overview.

Authors:  Giuseppe Scalabrino
Journal:  Cell Mol Neurobiol       Date:  2020-11-05       Impact factor: 5.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.